Combination treatments for allergic disease comprising administering an anti-IgE antibody and antiallergic compound
Pharmaceutical composition comprising an anti-IgE antibody and at least one further antiallergic compound selected from the group consisting of anti-inflammatory agents, leukotriene modifiers, bronchodilators, antihistamines, interleukin antagonists, mast cell inhibitors, and immunotherapeutical age...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
26.10.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Pharmaceutical composition comprising an anti-IgE antibody and at least one further antiallergic compound selected from the group consisting of anti-inflammatory agents, leukotriene modifiers, bronchodilators, antihistamines, interleukin antagonists, mast cell inhibitors, and immunotherapeutical agents, such as 33-epichloro,33-desoxyzascomycin (pimecrolimus), in which the active ingredients are present in each case in free form or in the form of a pharmaceutically acceptable salt and optionally at least one pharmaceutically acceptable carrier; for simultaneous, separate or sequential use. |
---|---|
Bibliography: | Application Number: US20060455431 |